Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1998Clinical Infectious Diseases

Topical Paromomycin/Methylbenzethonium Chloride Plus Parenteral Meglumine Antimonate as Treatment for American Cutaneous Leishmaniasis: Controlled Study

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJaime SotoFundación PROINPAPFPatricia FuyaNational Institute of HealthJBJ D BermanUniversity of Michigan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Soto et al. (1998) studied this question.

synapsesocial.com/papers/6a99d0f92a60c81fa4abff69https://doi.org/10.1086/516267
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Placebo-Controlled Clinical Trial of Meglumine Antimonate (Glucantime) Vs. Localized Controlled Heat in the Treatment of Cutaneous Leishmaniasis in Guatemala1990 · 124 citations
  2. 2Successful Treatment of New World Cutaneous Leishmaniasis with a Combination of Topical Paromomycin/Methylbenzethonium Chloride and Injectable Meglumine Antimonate1995 · 60 citations
  3. 3Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador1994 · 72 citations